Journals / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 4

The Frequency of Obstructive Sleep Apnea in Patients with Non-cystic Fibrosis Bronchiectasis

Pages
333–338
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Investigating OSA using PSG is important in patients with NCFB, especially at advanced ages.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Interruption or reduction in airflow and desaturation is a theoretically expected result in bronchiectasis accompanied by excessive secretions in the airways, bronchial wall thickening, and destruction of the wall structure.
📊
Key Findings & Data:We aimed to investigate the frequency of OSA and related parameters in patients with non-cystic fibrosis bronchiectasis (NCFB).MATERIAL AND METHODS: All 43 consecutive patients who presented to the outpatient clinic for bronchiectasis follow-up between January 1, 2018 and January 1, 2019 were included.
💡
Conclusion & Impact:Investigating OSA using PSG is important in patients with NCFB, especially at advanced ages.
🔬Design:Review & Systematic Survey
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: Interruption or reduction in airflow and desaturation is a theoretically expected result in bronchiectasis accompanied by excessive secretions in the airways, bronchial wall thickening, and destruction of the wall structure. The same mechanism of interruption or reduction in airflow and desaturation is valid for obstructive sleep apnea (OSA). However, data on the association of bronchiectasis with OSA are scarce. We aimed to investigate the frequency of OSA and related parameters in patients with non-cystic fibrosis bronchiectasis (NCFB).MATERIAL AND METHODS: All 43 consecutive patients who presented to the outpatient clinic for bronchiectasis follow-up between January 1, 2018 and January 1, 2019 were included. The polysomnography (PSG) data of the 43 patients were reviewed. Groups of patients with and without OSA, as detected using PSG, were compared in terms of clinical, demographic, and polysomnographic parameters.RESULTS: The mean age of the 43 patients was 50 ± 15 years; 28 (65.2%) were female. OSA was detected in 24 (55.8%) of 43 patients, of whom 14 (32.6%) had mild, 5 (11.6%) had moderate, and 5 (11.6%) had severe OSA. Three (7.0%) patients were REM-dependent and 7 (16.3%) were position-dependent. When evaluated using logistic regression analysis, REM percentage (16.8% vs. 11.8%, P = .03) and presence of witnessed apnea (33.3% vs. 15.7%, P = .01) were observed to be significantly higher in the patients with OSA. The age factor was found at the significance limit (P = .05).CONCLUSION: The frequency of OSA in patients with NCFB is 55.8%. Investigating OSA using PSG is important in patients with NCFB, especially at advanced ages.

🔖

Cite This Article

BÖREKÇİ, S., SEKİBAĞ, Y., HARBİYELİ, D. Ö., MÜSELLİM, B. (2021). The Frequency of Obstructive Sleep Apnea in Patients with Non-cystic Fibrosis Bronchiectasis. Turkish Thoracic Journal, Cilt: 22 - Sayı: 4, 333–338. https://ajindex.com/articles/417893

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Cao MT, Guilleminault C, Kushida CA. Clinical features and evaluation of obstructive sleep apnea and upper airway resistance syndrome. In: Principles and Practice of Sleep Medicine. Elsevier, Canada, 5th ed; 2011:1206-1218
  2. Jennum P, Tønnesen P, Ibsen R, Kjellberg J. All-cause mortality from obstructive sleep apnea in male and female patients with and without continuous positive airway pressure treatment: a registry study with 10 years of follow-up. Nat Sci Sleep. 2015;7:43-50. (doi:[CrossRef] 3. Heinzer R, Vat S, Marques-Vidal P et al. Prevalence of sleepdisordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310-318. [CrossRef] 4. Faria Júnior NS, Urbano JJ, Santos IR et al. Evaluation of obstructive sleep apnea in non-cystic fibrosis bronchiectasis: a cross-sectional study. PloS One. 2017;12(10):e0185413. [CrossRef] 5. Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis. 2017;14(4):377-384. [CrossRef] 6. Mysliwiec V, Pina JS. Bronchiectasis: the ‘other’ obstructive lung disease. Postgrad Med. 1999 July;106(1):123-6, 128, 128- 131. [CrossRef] 7. Martinez-Garcia MA, Polverino E, Aksamit T. Bronchiectasis and chronic airway disease: it is not just About asthma and COPD. Chest. 2018;154(4):737-739. [CrossRef] 8. Jankelowitz L, Reid KJ, Wolfe L et al. Cystic fibrosis patients have poor sleep quality despite normal sleep latency and efficiency. Chest. 2005;127(5):1593-1599. [CrossRef] 9. Santamaria F, Esposito M, Montella S et al. Sleep disordered breathing and airway disease in primary ciliary dyskinesia. Respirology. 2014;19(4):570-575. (doi:[CrossRef]
  3. Milross MA, Piper AJ, Norman M, et al. Subjective sleep quality in cystic fibrosis. Sleep Med. 2002;3(3):205-212. (doi:[CrossRef]
  4. Faria Júnior NSF, Oliveira LVF, Perez EA, et al. Observational study of sleep, respiratory mechanics and quality of life in patients with non-cystic fibrosis bronchiectasis: a protocol study. BMJ Open. 2015;5(7):e008183. [CrossRef] 12. Milliron B, Henry TS, Veeraraghavan S, Little BP. Bronchiectasis: mechanisms and imaging clues of associated common and uncommon diseases. RadioGraphics. 2015;35(4):1011-1030. [CrossRef] 13. Hill AT, Sullivan AL, Chalmers JD, et al. British Thoracic Society guideline for bronchiectasis in adults. BMJ Open Respir Res. 2018;5(1):e000348. [CrossRef] 14. Gramegna A, Aliberti S, Seia M et al. When and how ruling ou